title: No association between cSHMT genotypes and the risk of breast cancer in the Nurses' Health Study.
abstract: OBJECTIVE
  Increased breast cancer risk has been observed with both low folate status and a functional polymorphism in methylenetetrahydrofolate reductase (MTHFR 677C --> T). Cytoplasmic serine hydroxymethyltransferase (cSHMT) affects the flow of one-carbon units through the folate metabolic network, but there is little research on a role for genetic variation in cSHMT in determining breast cancer risk.
  
  
  METHODS
  A nested case-control study within the Nurses' Health Study was used to investigate an association between cSHMT (1420C --> T) and breast cancer risk.
  
  
  RESULTS
  No evidence for an association between the cSHMT genotype and breast cancer was observed. There was also no evidence of a gene-gene interaction between cSHMT and MTHFR.
  
  
  CONCLUSIONS
  There was no evidence of an association between the cSHMT genotype and breast cancer occurrence. Further research in populations with differing average folate intake may be required to fully understand the interactions of folate nutrition, sequence variation in folate genes and breast cancer risk.
authors.affiliation: Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
authors.forename: A R
authors.initials: AR
authors.lastname: Bentley
authors.forename: F
authors.initials: F
authors.lastname: Raiszadeh
authors.forename: P J
authors.initials: PJ
authors.lastname: Stover
authors.forename: D J
authors.initials: DJ
authors.lastname: Hunter
authors.forename: S E
authors.initials: SE
authors.lastname: Hankinson
authors.forename: P A
authors.initials: PA
authors.lastname: Cassano
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D012696:Glycine Hydroxymethyltransferase / Q000235:genetics*; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D009726:Nurses; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2); D012696:Glycine Hydroxymethyltransferase
references.citation: Int J Cancer. 2007 Jun 15;120(12):2696-703
references.pmid: 17311260
references.citation: Carcinogenesis. 2004 Feb;25(2):189-95
references.pmid: 14578164
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):190-6
references.pmid: 14973091
references.citation: Blood. 2002 May 15;99(10):3786-91
references.pmid: 11986237
references.citation: BMJ. 2005 Nov 5;331(7524):1053
references.pmid: 16216822
references.citation: J Biol Chem. 2002 Oct 11;277(41):38381-9
references.pmid: 12161434
references.citation: J Natl Cancer Inst. 2003 Mar 5;95(5):373-80
references.pmid: 12618502
references.citation: J Am Coll Nutr. 2005 Aug;24(4):266-74
references.pmid: 16093404
references.citation: J Nutr. 2005 Aug;135(8):1989-94
references.pmid: 16046727
references.citation: Cancer Res. 2005 Feb 15;65(4):1606-14
references.pmid: 15735051